The Role of COX-2 Inhibitors in Chronic Inflammatory Diseases
| dc.contributor.advisor | Pórszász, Róbert | |
| dc.contributor.advisordept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
| dc.contributor.author | Patel, Pooja Sundip | |
| dc.contributor.department | DE--Általános Orvostudományi Kar | hu_HU |
| dc.contributor.opponent | Szentmiklósi, József András | |
| dc.contributor.opponent | Drimba, László | |
| dc.contributor.opponentdept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
| dc.contributor.opponentdept | Kenézy Kórház Központi Aneszteziológiai és Intezív Terápiás Osztály | hu_HU |
| dc.date.accessioned | 2019-09-25T11:19:23Z | |
| dc.date.available | 2019-09-25T11:19:23Z | |
| dc.date.created | 2019-04-25 | |
| dc.description.abstract | Chronic inflammation is a slow, long term inflammation which lasts for a prolonged period, with a range from several months to years, which has now been ranked as one of the single greatest threats to human health by the World Health Organisation (WHO).In inflammatory conditions, COX-2 is increasingly produced by cytokines, growth factors and bacterial endotoxin, its enzymatic activity accounts for a large number of PGs produced during inflammation. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) are nonselective inhibitors for both COX isoforms. Inhibition of COX-2 leads to therapeutic inhibition of the synthesis of proinflammatory PGs, however, this inhibition can lead to side effects. New pharmaceutical drugs which are highly selective COX-2 inhibitors, celecoxib, etoricoxib, and diclofenac, have shown to be as effective as NSAIDs with reduced side effects on various chronic inflammatory diseases, for example, rheumatoid arthritis, COPD, Parkinson, Alzheimer’s, Cardiovascular Diseases et cetera. | hu_HU |
| dc.description.corrector | LB | |
| dc.description.course | általános orvos | hu_HU |
| dc.description.courselang | angol | hu_HU |
| dc.description.degree | egységes, osztatlan | hu_HU |
| dc.format.extent | 37 | hu_HU |
| dc.identifier.uri | http://hdl.handle.net/2437/273744 | |
| dc.language.iso | en | hu_HU |
| dc.subject | Cyclooxygenase | hu_HU |
| dc.subject | Cyclooxygenase 1 | hu_HU |
| dc.subject | Cyclooxygenase 2 | hu_HU |
| dc.subject | Nonsteroidal anti-inflammatory drugs | hu_HU |
| dc.subject | Prostaglandin | hu_HU |
| dc.subject | Prostacyclin | hu_HU |
| dc.subject | Inflammation | hu_HU |
| dc.subject | Chronic Diseases | hu_HU |
| dc.subject | Acute Inflammation | hu_HU |
| dc.subject | Chronic | hu_HU |
| dc.subject.dspace | DEENK Témalista::Orvostudomány::Farmakológia | hu_HU |
| dc.title | The Role of COX-2 Inhibitors in Chronic Inflammatory Diseases | hu_HU |